Brown Miller Wealth Management LLC Acquires 219 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Brown Miller Wealth Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,916 shares of the healthcare conglomerate’s stock after purchasing an additional 219 shares during the period. UnitedHealth Group makes up about 1.3% of Brown Miller Wealth Management LLC’s investment portfolio, making the stock its 21st largest position. Brown Miller Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,926,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. Richelieu Gestion SA bought a new position in UnitedHealth Group during the fourth quarter valued at $26,000. CGC Financial Services LLC grew its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. True Wealth Design LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $31,000. LFA Lugano Financial Advisors SA grew its holdings in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $40,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 4.7 %

Shares of UNH traded up $22.82 during mid-day trading on Friday, hitting $509.26. 22,734,197 shares of the company traded hands, compared to its average volume of 3,685,941. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $468.72 billion, a PE ratio of 31.13, a price-to-earnings-growth ratio of 1.41 and a beta of 0.58. The business has a 50 day moving average of $498.34 and a 200 day moving average of $501.96.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the company posted $6.26 earnings per share. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analyst Ratings Changes

A number of research firms have recently commented on UNH. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target on the stock in a report on Wednesday, June 5th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Barclays upped their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.